Tirzepatide is a dual GIP and GLP-1 receptor agonist, and BPC-157 is a synthetic peptide known for its role in cellular and tissue research. Together, they are studied for their potential synergistic effects on metabolic regulation and cellular protection pathways. Research investigates how this combination may influence glucose metabolism, inflammation control, and tissue homeostasis.
